Skip to Main Content

Paper Details

Evaluation of SARS-CoV-2 serology assays reveals a range of test performance.
Nat Biotechnol
209
2020
IgG antibodies, IgM, LFA, SARS, SARS-, SARS-CoV, SARS-CoV-2, anti-SARS-CoV-2 IgM, coronavirus disease, severe acute respiratory syndrome coronavirus
Adult, Aged, Aged, 80 and over, Antibodies, Viral, Betacoronavirus, Biotechnology, COVID-19, COVID-19 Testing, Chromatography, Affinity, Clinical Laboratory Techniques, Coronavirus Infections, Enzyme-Linked Immunosorbent Assay, Female, Humans, Immunoglobulin G, Immunoglobulin M, Male, Middle Aged, Pandemics, Pneumonia, Viral, Point-of-Care Testing, Reverse Transcriptase Polymerase Chain Reaction, SARS-CoV-2, Sensitivity and Specificity, Young Adult
Author NameAffiliation
Jeffrey D WhitmanUniversity of California san francisco
Joseph B HiattUniversity of California san francisco
Joseph B HiattDiabetes Center, University of California san francisco
Joseph B HiattInnovative Genomics Institute, University of California berkeley
Joseph B HiattUniversity of California san francisco
Joseph B HiattJ. David Gladstone Institutes
Joseph B HiattUniversity of California san francisco
Cody T MoweryUniversity of California san francisco
Cody T MoweryDiabetes Center, University of California san francisco
Cody T MoweryInnovative Genomics Institute, University of California berkeley
Cody T MoweryUniversity of California san francisco
Cody T MoweryUniversity of California san francisco
Brian R ShyUniversity of California san francisco
Ruby YuUniversity of California san francisco
Ruby YuDiabetes Center, University of California san francisco
Tori N YamamotoUniversity of California san francisco
Tori N YamamotoDiabetes Center, University of California san francisco
Ujjwal RathoreJ. David Gladstone Institutes
Ujjwal RathoreDiabetes Center, University of California san francisco
Ujjwal RathoreInnovative Genomics Institute, University of California berkeley
Ujjwal RathoreUniversity of California san francisco
Gregory M GoldgofUniversity of California san francisco
Caroline WhittyUniversity of California san francisco
Caroline WhittyDiabetes Center, University of California san francisco
Caroline WhittyUniversity of California san francisco
Jonathan M WooUniversity of California san francisco
Jonathan M WooDiabetes Center, University of California san francisco
Jonathan M WooInnovative Genomics Institute, University of California berkeley
Antonia E GallmanUniversity of California san francisco
Antonia E GallmanHoward Hughes Medical Institute, University of California san francisco
Antonia E GallmanUniversity of California san francisco
Tyler E MillerMassachusetts General Hospital/Harvard Medical School
Andrew G LevineUniversity of California san francisco
David N NguyenUniversity of California san francisco
David N NguyenUniversity of California san francisco
David N NguyenInnovative Genomics Institute, University of California berkeley
Sagar P BapatUniversity of California san francisco
Sagar P BapatDiabetes Center, University of California san francisco
Sagar P BapatUniversity of California san francisco
Joanna BalcerekUniversity of California san francisco
Sophia A BylsmaUniversity of California berkeley
Ana M LyonsUniversity of California berkeley
Stacy LiUniversity of California berkeley
Allison W WongUniversity of California san francisco
Eva M Gillis-BuckUniversity of California san francisco
Zachary SteinhartUniversity of California san francisco
Zachary SteinhartDiabetes Center, University of California san francisco
Youjin V LeeUniversity of California san francisco
Ryan ApathyUniversity of California san francisco
Ryan ApathyDiabetes Center, University of California san francisco
  • 1 - 50

Datasets